BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1389 related articles for article (PubMed ID: 22041457)

  • 1. Wnt/β-catenin pathway forms a negative feedback loop during TGF-β1 induced human normal skin fibroblast-to-myofibroblast transition.
    Liu J; Wang Y; Pan Q; Su Y; Zhang Z; Han J; Zhu X; Tang C; Hu D
    J Dermatol Sci; 2012 Jan; 65(1):38-49. PubMed ID: 22041457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of Wnt/beta-catenin signaling on the phenotype change of human dermal fibroblasts and its mechanism].
    Liu JQ; Pan Q; Wang YC; Liu Y; Wang YJ; Bai L; Bai XZ; Hu DH
    Zhonghua Shao Shang Za Zhi; 2012 Aug; 28(4):282-7. PubMed ID: 23248963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smad7 blocks transforming growth factor-β1-induced gingival fibroblast-myofibroblast transition via inhibitory regulation of Smad2 and connective tissue growth factor.
    Sobral LM; Montan PF; Zecchin KG; Martelli-Junior H; Vargas PA; Graner E; Coletta RD
    J Periodontol; 2011 Apr; 82(4):642-51. PubMed ID: 21054221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids.
    Sato M
    Acta Derm Venereol; 2006; 86(4):300-7. PubMed ID: 16874413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between myofibroblast differentiation and epidermogenesis in constructing human living skin equivalents.
    Yang L; Hashimoto K; Tohyama M; Okazaki H; Dai X; Hanakawa Y; Sayama K; Shirakata Y
    J Dermatol Sci; 2012 Jan; 65(1):50-7. PubMed ID: 22169155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of IFN-gamma and dexamethasone on TGF-beta1-induced human fetal lung fibroblast-myofibroblast differentiation.
    Gu L; Zhu YJ; Guo ZJ; Xu XX; Xu WB
    Acta Pharmacol Sin; 2004 Nov; 25(11):1479-88. PubMed ID: 15525471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt4 negatively regulates the TGF-β1-induced human dermal fibroblast-to-myofibroblast transition via targeting Smad3 and ERK.
    Liu J; Zhao B; Zhu H; Pan Q; Cai M; Bai X; Li X; Hu X; Zhang M; Shi J; Zheng Z; Yang A; Hu D
    Cell Tissue Res; 2020 Mar; 379(3):537-548. PubMed ID: 31776823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human decorin inhibits TGF-beta1-induced contraction of collagen lattice by hypertrophic scar fibroblasts.
    Zhang Z; Garron TM; Li XJ; Liu Y; Zhang X; Li YY; Xu WS
    Burns; 2009 Jun; 35(4):527-37. PubMed ID: 19167828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of the myofibroblastic phenotype in human gingival fibroblasts by transforming growth factor-beta1: role of RhoA-ROCK and c-Jun N-terminal kinase signaling pathways.
    Smith PC; Cáceres M; Martinez J
    J Periodontal Res; 2006 Oct; 41(5):418-25. PubMed ID: 16953819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
    Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
    Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-β1 involved in urotensin II-induced phenotypic differentiation of adventitial fibroblasts from rat aorta.
    Zhang YG; Hu YC; Mao YY; Wei RH; Bao SL; Wu LB; Kuang ZJ
    Chin Med J (Engl); 2010 Dec; 123(24):3634-9. PubMed ID: 22166643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta 1 modulates myofibroblastic phenotype of rat palatal fibroblasts in vitro.
    Yokozeki M; Moriyama K; Shimokawa H; Kuroda T
    Exp Cell Res; 1997 Mar; 231(2):328-36. PubMed ID: 9087174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contractility as a prerequisite for TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts.
    Meyer-ter-Vehn T; Sieprath S; Katzenberger B; Gebhardt S; Grehn F; Schlunck G
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4895-904. PubMed ID: 17065504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Smad protein by normal skin fibroblasts and hypertrophic scar fibroblasts in response to transforming growth factor beta1.
    Xie JL; Qi SH; Pan S; Xu YB; Li TZ; Liu XS; Liu P
    Dermatol Surg; 2008 Sep; 34(9):1216-24; discussion 1224-5. PubMed ID: 18616749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human xylosyltransferase-I - a new marker for myofibroblast differentiation in skin fibrosis.
    Faust I; Roch C; Kuhn J; Prante C; Knabbe C; Hendig D
    Biochem Biophys Res Commun; 2013 Jul; 436(3):449-54. PubMed ID: 23747722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of fibroblast growth factor (FGF) 9 expression and FGF-WNT/β-catenin signaling in laser-induced wound healing.
    Zheng Z; Kang HY; Lee S; Kang SW; Goo B; Cho SB
    Wound Repair Regen; 2014; 22(5):660-5. PubMed ID: 25041895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta-stimulated connective tissue growth factor expression during corneal myofibroblast differentiation.
    Folger PA; Zekaria D; Grotendorst G; Masur SK
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2534-41. PubMed ID: 11581194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of simvastatin on transforming growth factor beta-1-induced myofibroblast differentiation and collagen production in nasal polyp-derived fibroblasts.
    Park IH; Park SJ; Cho JS; Moon YM; Moon JH; Kim TH; Lee SH; Lee HM
    Am J Rhinol Allergy; 2012; 26(1):7-11. PubMed ID: 22391067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor reversal of the corneal myofibroblast phenotype.
    Maltseva O; Folger P; Zekaria D; Petridou S; Masur SK
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2490-5. PubMed ID: 11581188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p38 inhibitors prevent TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts.
    Meyer-Ter-Vehn T; Gebhardt S; Sebald W; Buttmann M; Grehn F; Schlunck G; Knaus P
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1500-9. PubMed ID: 16565385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.